Target- |
Mechanism- |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Phase I/II, Two- Staged Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Nowarta110 in Patients With Plantar Warts and Clinical Recovery Successfully Completed
To evaluate drug safety and efficacy in patients treated with Nowarta110 and to determine therapeutic activity against Plantar Warts
Clinical Tolerance
Clinical Recovery
Evaluate Safety
100 Clinical Results associated with Nowarta Biopharma
0 Patents (Medical) associated with Nowarta Biopharma
100 Deals associated with Nowarta Biopharma
100 Translational Medicine associated with Nowarta Biopharma